Health

CVS Lets Down Wall Street With Reaffirmed Profit Guidance

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Ike Swetlitz

February 10, 2026 at 11:30 AM UTC

Updated on

February 10, 2026 at 2:34 PM UTC

CVS Health Corp. disappointed Wall Street by reiterating its profit guidance for 2026, a move analysts are calling a letdown after a strong fourth-quarter performance.

The company said it still sees 2026 adjusted earnings of $7 to $7.20 a share. The midpoint was below the average analyst estimate of $7.17 a share.